Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Opiant Pharmaceuticals, Inc. (MDRV) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Opiant Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1385508.
Total stock buying since 2015: $1,325,880.
Total stock sales since 2015: $13,144,086.
Total stock option exercises since 2015: $3,880,848.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 3,433 | $69,550 | 0 | $0 |
| 2022 | 42,039 | $535,571 | 61,963 | $855,216 | 0 | $0 |
| 2021 | 16,289 | $294,438 | 182,120 | $2,764,030 | 204,661 | $1,296,610 |
| 2020 | 7,730 | $69,689 | 10,000 | $135,327 | 10,000 | $90,000 |
| 2019 | 11,785 | $170,267 | 280,000 | $3,642,956 | 250,000 | $2,083,972 |
| 2018 | 10,000 | $173,465 | 50,497 | $888,889 | 50,497 | $410,266 |
| 2017 | 11,795 | $82,450 | 211,224 | $4,782,168 | 0 | $0 |
| 2015 | 0 | $0 | 1,700 | $5,950 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-01 | 0 | $0 | 3,433 | $69,550 | 0 | $0 |
| 2022-07 | 0 | $0 | 5,427 | $60,251 | 0 | $0 |
| 2022-06 | 5,700 | $63,265 | 51,148 | $645,825 | 0 | $0 |
| 2022-05 | 36,339 | $472,306 | 0 | $0 | 0 | $0 |
| 2022-01 | 0 | $0 | 5,388 | $149,140 | 0 | $0 |
| 2021-09 | 13,689 | $250,530 | 3,959 | $83,428 | 8,334 | $83,340 |
| 2021-08 | 2,600 | $43,908 | 151,000 | $2,372,897 | 150,000 | $750,000 |
| 2021-05 | 0 | $0 | 0 | $0 | 365 | $3,650 |
| 2021-03 | 0 | $0 | 27,161 | $307,705 | 38,962 | $389,620 |
| 2021-02 | 0 | $0 | 0 | $0 | 7,000 | $70,000 |
| 2020-09 | 3,000 | $25,025 | 0 | $0 | 0 | $0 |
| 2020-06 | 3,730 | $33,664 | 0 | $0 | 0 | $0 |
| 2020-05 | 1,000 | $11,000 | 0 | $0 | 0 | $0 |
| 2020-01 | 0 | $0 | 10,000 | $135,327 | 10,000 | $90,000 |
| 2019-12 | 5,000 | $72,700 | 10,000 | $139,052 | 10,000 | $90,000 |
| 2019-11 | 2,985 | $41,887 | 10,000 | $150,528 | 10,000 | $90,000 |
| 2019-10 | 0 | $0 | 10,000 | $146,820 | 10,000 | $90,000 |
| 2019-09 | 1,800 | $25,020 | 70,000 | $892,722 | 10,000 | $90,000 |
| 2019-08 | 2,000 | $30,660 | 10,000 | $116,038 | 10,000 | $90,000 |
| 2019-07 | 0 | $0 | 10,000 | $131,912 | 40,000 | $390,000 |
| 2019-06 | 0 | $0 | 10,000 | $117,057 | 10,000 | $90,000 |
| 2019-05 | 0 | $0 | 10,000 | $113,854 | 10,000 | $90,000 |
| 2019-04 | 0 | $0 | 60,000 | $727,592 | 60,000 | $452,499 |
| 2019-03 | 0 | $0 | 10,000 | $149,650 | 10,000 | $90,000 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-27 | Gorman Brian | Sale | 444 | 20.26 | 8,995 |
| 2023-01-27 | Ellison Mark Jason Heath (Chief Development Officer) | Sale | 610 | 20.26 | 12,358 |
| 2023-01-27 | Crystal Roger (Chief Executive Officer) | Sale | 1,358 | 20.26 | 27,513 |
| 2023-01-27 | O'toole David D (Chief Financial Officer) | Sale | 541 | 20.26 | 10,960 |
| 2023-01-27 | Skolnick Phil (Chief Scientific Officer) | Sale | 480 | 20.26 | 9,724 |
| 2022-07-20 | Ruth Matthew R. (Chief Commercial Officer) | Sale | 1,084 | 10.62 | 11,512 |
| 2022-07-14 | Gorman Brian | Sale | 691 | 11.16 | 7,711 |
| 2022-07-14 | Crystal Roger (Chief Executive Officer) | Sale | 2,246 | 11.11 | 24,953 |
| 2022-07-14 | O'toole David D (Chief Financial Officer) | Sale | 779 | 11.10 | 8,646 |
| 2022-07-14 | Skolnick Phil (Chief Scientific Officer) | Sale | 627 | 11.85 | 7,429 |
| 2022-06-15 | Sinclair Michael | Sale | 900 | 10.60 | 9,540 |
| 2022-06-14 | Sinclair Michael | Sale | 7,225 | 10.90 | 78,752 |
| 2022-06-13 | Sinclair Michael | Sale | 5,491 | 11.09 | 60,895 |
| 2022-06-13 | Collard Craig A | Buy | 4,037 | 10.94 | 44,148 |
| 2022-06-10 | Collard Craig A | Buy | 1,663 | 11.50 | 19,117 |
| 2022-06-09 | Sinclair Michael | Sale | 7,896 | 12.25 | 96,726 |
| 2022-06-07 | Sinclair Michael | Sale | 800 | 12.86 | 10,288 |
| 2022-06-06 | Sinclair Michael | Sale | 7,688 | 12.94 | 99,482 |
| 2022-06-03 | Sinclair Michael | Sale | 10,264 | 13.59 | 139,487 |
| 2022-06-02 | Gorman Brian | Sale | 1,148 | 13.52 | 15,520 |
| 2022-06-02 | Sinclair Michael | Sale | 9,736 | 13.88 | 135,135 |
| 2022-05-16 | Silver Gabrielle Alison | Buy | 2,500 | 13.29 | 33,220 |
| 2022-05-16 | Collard Craig A | Buy | 27,150 | 13.54 | 367,611 |
| 2022-05-13 | Macdougall Ann L. | Buy | 3,000 | 10.93 | 32,778 |
| 2022-05-13 | Collard Craig A | Buy | 3,689 | 10.49 | 38,697 |
| 2022-01-27 | Crystal Roger (Chief Executive Officer) | Sale | 1,995 | 26.15 | 52,169 |
| 2022-01-27 | Skolnick Phil (Chief Scientific Officer) | Sale | 1,518 | 26.19 | 39,756 |
| 2022-01-10 | Crystal Roger (Chief Executive Officer) | Sale | 1,058 | 30.49 | 32,258 |
| 2022-01-10 | O'toole David D (Chief Financial Officer) | Sale | 432 | 30.60 | 13,219 |
| 2022-01-10 | Skolnick Phil (Chief Scientific Officer) | Sale | 385 | 30.49 | 11,738 |
| 2021-09-22 | Thomas Thomas T. | Sale | 735 | 25.02 | 18,389 |
| 2021-09-22 | Thomas Thomas T. | Option Ex | 1,834 | 10.00 | 18,340 |
| 2021-09-21 | Thomas Thomas T. | Sale | 831 | 24.09 | 20,022 |
| 2021-09-21 | Thomas Thomas T. | Option Ex | 2,000 | 10.00 | 20,000 |
| 2021-09-16 | Crystal Roger (Chief Executive Officer) | Buy | 100 | 23.44 | 2,344 |
| 2021-09-14 | Gorman Brian | Buy | 1,312 | 19.00 | 24,934 |
| 2021-09-14 | Thomas Thomas T. | Sale | 1,571 | 19.24 | 30,221 |
| 2021-09-14 | Thomas Thomas T. | Option Ex | 3,025 | 10.00 | 30,250 |
| 2021-09-14 | O'toole David D (Chief Financial Officer) | Buy | 200 | 19.09 | 3,818 |
| 2021-09-13 | Collard Craig A | Buy | 2,500 | 18.13 | 45,325 |
| 2021-09-10 | Collard Craig A | Buy | 9,577 | 18.18 | 174,109 |
| 2021-09-07 | Thomas Thomas T. | Sale | 822 | 18.00 | 14,796 |
| 2021-09-07 | Thomas Thomas T. | Option Ex | 1,475 | 10.00 | 14,750 |
| 2021-08-31 | Ruth Matthew R. (Chief Commercial Officer) | Buy | 2,000 | 17.34 | 34,680 |
| 2021-08-25 | Sinclair Michael | Sale | 50,269 | 14.69 | 738,451 |
| 2021-08-25 | Sinclair Michael | Option Ex | 50,269 | 5.00 | 251,345 |
| 2021-08-24 | Sinclair Michael | Sale | 34,607 | 15.71 | 543,675 |
| 2021-08-24 | Sinclair Michael | Option Ex | 34,607 | 5.00 | 173,035 |
| 2021-08-23 | Sinclair Michael | Sale | 65,124 | 16.50 | 1,074,546 |
| 2021-08-23 | Sinclair Michael | Option Ex | 65,124 | 5.00 | 325,620 |
| 2021-08-19 | Thomas Thomas T. | Sale | 1,000 | 16.23 | 16,225 |
| 2021-08-16 | O'toole David D (Chief Financial Officer) | Buy | 600 | 15.38 | 9,228 |
| 2021-05-13 | Silver Gabrielle Alison | Option Ex | 365 | 10.00 | 3,650 |
| 2021-03-17 | Macdougall Ann L. | Sale | 6,606 | 11.07 | 73,128 |
| 2021-03-17 | Macdougall Ann L. | Option Ex | 7,279 | 10.00 | 72,790 |
| 2021-03-17 | Silver Gabrielle Alison | Sale | 7,157 | 11.07 | 79,227 |
| 2021-03-17 | Silver Gabrielle Alison | Option Ex | 7,886 | 10.00 | 78,860 |
| 2021-03-16 | Macdougall Ann L. | Sale | 1,949 | 11.50 | 22,413 |
| 2021-03-16 | Macdougall Ann L. | Option Ex | 2,231 | 10.00 | 22,310 |
| 2021-03-16 | Silver Gabrielle Alison | Sale | 1,949 | 11.50 | 22,413 |
| 2021-03-16 | Silver Gabrielle Alison | Option Ex | 2,231 | 10.00 | 22,310 |
| 2021-03-15 | Macdougall Ann L. | Sale | 5,600 | 11.63 | 65,128 |
| 2021-03-15 | Macdougall Ann L. | Option Ex | 6,483 | 10.00 | 64,830 |
| 2021-03-15 | Silver Gabrielle Alison | Sale | 3,900 | 11.64 | 45,396 |
| 2021-03-15 | Silver Gabrielle Alison | Option Ex | 4,518 | 10.00 | 45,180 |
| 2021-03-05 | Silver Gabrielle Alison | Option Ex | 8,334 | 10.00 | 83,340 |
| 2021-02-11 | Macdougall Ann L. | Option Ex | 7,000 | 10.00 | 70,000 |
| 2020-09-04 | Thomas Thomas T. | Buy | 500 | 8.05 | 4,025 |
| 2020-09-03 | Thomas Thomas T. | Buy | 2,500 | 8.40 | 21,000 |
| 2020-06-11 | O'toole David D (Chief Financial Officer) | Buy | 1,000 | 8.74 | 8,740 |
| 2020-06-10 | Silver Gabrielle Alison | Buy | 2,730 | 9.13 | 24,924 |
| 2020-05-26 | O'toole David D (Chief Financial Officer) | Buy | 1,000 | 11.00 | 11,000 |
| 2020-01-08 | Skolnick Phil (Chief Scientific Officer) | Sale | 2,842 | 13.46 | 38,253 |
| 2020-01-07 | Skolnick Phil (Chief Scientific Officer) | Sale | 5,943 | 13.48 | 80,111 |
| 2020-01-06 | Skolnick Phil (Chief Scientific Officer) | Sale | 515 | 13.80 | 7,107 |
| 2020-01-02 | Skolnick Phil (Chief Scientific Officer) | Sale | 700 | 14.08 | 9,856 |
| 2020-01-02 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 10,000 | 9.00 | 90,000 |
| 2019-12-12 | Macdougall Ann L. | Buy | 5,000 | 14.54 | 72,700 |
| 2019-12-06 | Skolnick Phil (Chief Scientific Officer) | Sale | 800 | 13.34 | 10,672 |
| 2019-12-05 | Skolnick Phil (Chief Scientific Officer) | Sale | 2,057 | 13.74 | 28,263 |
| 2019-12-03 | Skolnick Phil (Chief Scientific Officer) | Sale | 4,578 | 13.93 | 63,771 |
| 2019-12-02 | Skolnick Phil (Chief Scientific Officer) | Sale | 2,565 | 14.17 | 36,346 |
| 2019-12-02 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 10,000 | 9.00 | 90,000 |
| 2019-11-26 | O'toole David D (Chief Financial Officer) | Buy | 100 | 13.22 | 1,322 |
| 2019-11-22 | Silver Gabrielle Alison | Buy | 1,785 | 13.51 | 24,115 |
| 2019-11-15 | O'toole David D (Chief Financial Officer) | Buy | 1,100 | 14.96 | 16,450 |
| 2019-11-05 | Skolnick Phil (Chief Scientific Officer) | Sale | 2,500 | 14.89 | 37,225 |
| 2019-11-04 | Skolnick Phil (Chief Scientific Officer) | Sale | 299 | 15.28 | 4,568 |
| 2019-11-01 | Skolnick Phil (Chief Scientific Officer) | Sale | 7,201 | 15.10 | 108,735 |
| 2019-11-01 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 10,000 | 9.00 | 90,000 |
| 2019-10-03 | Skolnick Phil (Chief Scientific Officer) | Sale | 1,609 | 14.27 | 22,960 |
| 2019-10-02 | Skolnick Phil (Chief Scientific Officer) | Sale | 1,102 | 14.57 | 16,056 |
| 2019-10-01 | Skolnick Phil (Chief Scientific Officer) | Sale | 7,289 | 14.79 | 107,804 |
| 2019-10-01 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 10,000 | 9.00 | 90,000 |
| 2019-09-12 | Daly Richard J | Buy | 1,800 | 13.90 | 25,020 |
| 2019-09-12 | Sinclair Michael | Sale | 60,000 | 12.52 | 751,200 |
| 2019-09-04 | Skolnick Phil (Chief Scientific Officer) | Sale | 2,494 | 14.37 | 35,838 |
| 2019-09-03 | Skolnick Phil (Chief Scientific Officer) | Sale | 7,506 | 14.08 | 105,684 |
| 2019-09-03 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 10,000 | 9.00 | 90,000 |
| 2019-08-15 | O'toole David D (Chief Financial Officer) | Buy | 1,000 | 15.20 | 15,200 |
| 2019-08-13 | O'toole David D (Chief Financial Officer) | Buy | 1,000 | 15.46 | 15,460 |
| 2019-08-02 | Skolnick Phil (Chief Scientific Officer) | Sale | 1,558 | 11.30 | 17,605 |
| 2019-08-01 | Skolnick Phil (Chief Scientific Officer) | Sale | 8,442 | 11.66 | 98,433 |
| 2019-08-01 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 10,000 | 9.00 | 90,000 |
| 2019-07-29 | Ellison Mark Jason Heath | Option Ex | 30,000 | 10.00 | 300,000 |
| 2019-07-02 | Skolnick Phil (Chief Scientific Officer) | Sale | 2,195 | 13.16 | 28,886 |
| 2019-07-01 | Skolnick Phil (Chief Scientific Officer) | Sale | 7,805 | 13.20 | 103,026 |
| 2019-07-01 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 10,000 | 9.00 | 90,000 |
| 2019-06-04 | Skolnick Phil (Chief Scientific Officer) | Sale | 1,586 | 11.63 | 18,445 |
| 2019-06-03 | Skolnick Phil (Chief Scientific Officer) | Sale | 8,414 | 11.72 | 98,612 |
| 2019-06-03 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 10,000 | 9.00 | 90,000 |
| 2019-05-02 | Skolnick Phil (Chief Scientific Officer) | Sale | 1,441 | 11.24 | 16,196 |
| 2019-05-01 | Skolnick Phil (Chief Scientific Officer) | Sale | 8,559 | 11.41 | 97,658 |
| 2019-05-01 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 10,000 | 9.00 | 90,000 |
| 2019-04-08 | Crystal Roger (Chief Executive Officer) | Sale | 12,772 | 12.10 | 154,541 |
| 2019-04-05 | Crystal Roger (Chief Executive Officer) | Sale | 16,001 | 11.98 | 191,691 |
| 2019-04-05 | Crystal Roger (Chief Executive Officer) | Option Ex | 21,472 | 7.25 | 155,672 |
| 2019-04-04 | Crystal Roger (Chief Executive Officer) | Sale | 16,836 | 11.93 | 200,853 |
| 2019-04-04 | Crystal Roger (Chief Executive Officer) | Option Ex | 22,557 | 7.25 | 163,538 |
| 2019-04-03 | Crystal Roger (Chief Executive Officer) | Sale | 3,791 | 12.24 | 46,401 |
| 2019-04-03 | Crystal Roger (Chief Executive Officer) | Option Ex | 5,149 | 7.25 | 37,330 |
| 2019-04-02 | Crystal Roger (Chief Executive Officer) | Sale | 600 | 12.48 | 7,488 |
| 2019-04-02 | Crystal Roger (Chief Executive Officer) | Option Ex | 822 | 7.25 | 5,959 |
| 2019-04-02 | Skolnick Phil (Chief Scientific Officer) | Sale | 2,007 | 12.47 | 25,027 |
| 2019-04-01 | Skolnick Phil (Chief Scientific Officer) | Sale | 7,993 | 12.71 | 101,591 |
| 2019-04-01 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 10,000 | 9.00 | 90,000 |
| 2019-03-01 | Skolnick Phil (Chief Scientific Officer) | Sale | 10,000 | 14.96 | 149,650 |
| 2019-03-01 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 10,000 | 9.00 | 90,000 |
| 2019-02-04 | Skolnick Phil (Chief Scientific Officer) | Sale | 2,559 | 15.31 | 39,178 |
| 2019-02-01 | Skolnick Phil (Chief Scientific Officer) | Sale | 7,441 | 15.32 | 113,996 |
| 2019-02-01 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 10,000 | 9.00 | 90,000 |
| 2019-01-08 | Crystal Roger (Chief Executive Officer) | Sale | 11,407 | 13.27 | 151,370 |
| 2019-01-07 | Crystal Roger (Chief Executive Officer) | Sale | 26,759 | 13.28 | 355,359 |
| 2019-01-07 | Crystal Roger (Chief Executive Officer) | Option Ex | 33,641 | 6.62 | 222,871 |
| 2019-01-04 | Crystal Roger (Chief Executive Officer) | Sale | 11,834 | 13.54 | 160,232 |
| 2019-01-04 | Crystal Roger (Chief Executive Officer) | Option Ex | 16,359 | 7.25 | 118,602 |
| 2019-01-04 | Skolnick Phil (Chief Scientific Officer) | Sale | 2,232 | 13.48 | 30,087 |
| 2019-01-02 | Skolnick Phil (Chief Scientific Officer) | Sale | 7,768 | 13.84 | 107,509 |
| 2019-01-02 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 10,000 | 9.00 | 90,000 |
| 2018-12-06 | Skolnick Phil (Chief Scientific Officer) | Sale | 3,015 | 16.15 | 48,692 |
| 2018-12-03 | Skolnick Phil (Chief Scientific Officer) | Sale | 1,306 | 15.85 | 20,700 |
| 2018-12-03 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 4,321 | 9.00 | 38,889 |
| 2018-11-06 | Skolnick Phil (Chief Scientific Officer) | Sale | 3,217 | 16.81 | 54,077 |
| 2018-11-05 | Skolnick Phil (Chief Scientific Officer) | Sale | 300 | 17.33 | 5,198 |
| 2018-11-01 | Skolnick Phil (Chief Scientific Officer) | Sale | 1,521 | 18.14 | 27,590 |
| 2018-11-01 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 5,038 | 9.00 | 45,342 |
| 2018-10-09 | Crystal Roger (Chief Executive Officer) | Sale | 6,941 | 17.04 | 118,274 |
| 2018-10-08 | Crystal Roger (Chief Executive Officer) | Sale | 3,059 | 17.33 | 53,012 |
| 2018-10-05 | Crystal Roger (Chief Executive Officer) | Sale | 847 | 18.14 | 15,364 |
| 2018-10-04 | Crystal Roger (Chief Executive Officer) | Sale | 4,006 | 18.43 | 73,830 |
| 2018-10-04 | Skolnick Phil (Chief Scientific Officer) | Sale | 1,845 | 18.43 | 34,003 |
| 2018-10-03 | Crystal Roger (Chief Executive Officer) | Sale | 4,300 | 19.23 | 82,689 |
| 2018-10-03 | Skolnick Phil (Chief Scientific Officer) | Sale | 1,500 | 19.23 | 28,837 |
| 2018-10-02 | Crystal Roger (Chief Executive Officer) | Sale | 10,144 | 17.51 | 177,621 |
| 2018-10-02 | Crystal Roger (Chief Executive Officer) | Option Ex | 29,297 | 7.25 | 212,403 |
| 2018-10-02 | Skolnick Phil (Chief Scientific Officer) | Sale | 1,433 | 17.24 | 24,704 |
| 2018-10-02 | Skolnick Phil (Chief Scientific Officer) | Option Ex | 4,778 | 9.00 | 43,002 |
| 2018-06-04 | Macdougall Ann L. | Buy | 5,000 | 16.60 | 83,015 |
| 2018-05-18 | Thomas Thomas T. | Sale | 500 | 16.50 | 8,250 |
| 2018-05-17 | Thomas Thomas T. | Sale | 1,500 | 16.47 | 24,705 |
| 2018-05-16 | Thomas Thomas T. | Sale | 763 | 16.29 | 12,429 |
| 2018-05-16 | O'toole David D (Chief Financial Officer) | Buy | 2,000 | 16.95 | 33,900 |
| 2018-05-15 | Thomas Thomas T. | Sale | 800 | 17.53 | 14,024 |
| 2018-05-14 | Thomas Thomas T. | Sale | 3,500 | 18.54 | 64,890 |
| 2018-05-11 | Thomas Thomas T. | Option Ex | 7,063 | 10.00 | 70,630 |
| 2018-05-11 | O'toole David D (Chief Financial Officer) | Buy | 3,000 | 18.85 | 56,550 |
| 2017-12-28 | Wolf Geoffrey | Sale | 43,000 | 22.52 | 968,360 |
| 2017-12-27 | Wolf Geoffrey | Sale | 37,850 | 21.51 | 814,153 |
| 2017-12-21 | Wolf Geoffrey | Sale | 20,000 | 24.17 | 483,400 |
| 2017-12-20 | Wolf Geoffrey | Sale | 69,016 | 22.75 | 1,570,114 |
| 2017-12-19 | Wolf Geoffrey | Sale | 3,850 | 19.69 | 75,806 |
| 2017-12-18 | Wolf Geoffrey | Sale | 27,134 | 20.68 | 561,131 |
| 2017-12-13 | Wolf Geoffrey | Sale | 7,804 | 29.61 | 231,076 |
| 2017-12-08 | Wolf Geoffrey | Sale | 2,570 | 30.40 | 78,128 |
| 2017-01-17 | Crystal Roger (Chief Executive Officer) | Buy | 3,475 | 6.99 | 24,290 |
| 2017-01-17 | Sinclair Michael (Executive Chairman) | Buy | 3,500 | 7.00 | 24,517 |
| 2017-01-13 | Pollack Kevin (See Remarks) | Buy | 4,820 | 6.98 | 33,643 |
| 2015-01-15 | Sinclair Michael (Executive Chairman) | Sale | 1,700 | 3.50 | 5,950 |
Insider trading activities including stock purchases, stock sales, and option exercises of MDRV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Opiant Pharmaceuticals, Inc. (symbol MDRV, CIK number 1385508) see the Securities and Exchange Commission (SEC) website.